Brown Brothers Harriman & Co’s CONMED CNMD Stock Holding History

Brown Brothers Harriman & Co’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-25	Closed	-$1.8K	–	1487
2024 Q3	$1.8K	Buy	+25	New	+$1.76K	﹤0.01%	1316
2024 Q1	–	Sell	-250	Closed	-$27.4K	–	1179
2023 Q4	$27.4K	Hold	250	–	–	﹤0.01%	803
2023 Q3	$25.2K	Hold	250	–	–	﹤0.01%	800
2023 Q2	$34K	Hold	250	–	–	﹤0.01%	773
2023 Q1	$26K	Hold	250	–	–	﹤0.01%	847
2022 Q4	$22.2K	Sell	250 -375	-60%	-$31.1K	﹤0.01%	859
2022 Q3	$50K	Buy	625 +314	+101%	+$29.6K	﹤0.01%	735
2022 Q2	$30K	Sell	311 -14	-4%	-$1.68K	﹤0.01%	796
2022 Q1	$48K	Buy	325 +75	+30%	+$10.5K	﹤0.01%	774
2021 Q4	$35	Hold	250	–	–	﹤0.01%	757
2021 Q3	$33	Hold	250	–	–	﹤0.01%	740
2021 Q2	$34	Hold	250	–	–	﹤0.01%	732
2021 Q1	$33	Sell	250 -250	-50%	-$30.1K	﹤0.01%	706
2020 Q4	$56K	Hold	500	–	–	﹤0.01%	645
2020 Q3	$39K	Hold	500	–	–	﹤0.01%	616
2020 Q2	$36K	Hold	500	–	–	﹤0.01%	611
2020 Q1	$29K	Hold	500	–	–	﹤0.01%	582
2019 Q4	$56K	Hold	500	–	–	﹤0.01%	641
2019 Q3	$48K	Hold	500	–	–	﹤0.01%	650
2019 Q2	$43K	Sell	500 -500	-50%	-$41.1K	﹤0.01%	609
2019 Q1	$83K	Buy	+1,000	New	+$72.7K	﹤0.01%	509

Other funds holding CNMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Brown Brothers Harriman & Co's CNMD Position: Q4 2024 in Review

Brown Brothers Harriman & Co sold out of CONMED (CNMD) in Q4 2024, closing a stake of 25 shares — an estimated $1.8K sold.

Brown Brothers Harriman & Co first reported a position in CNMD in Q1 2019 and held it in 21 quarters. The position peaked at $83K in Q1 2019. 280 funds tracked by Wall St. Rank hold CNMD as of Q4 2024.

Brown Brothers Harriman & Co reported no remaining CONMED position as of Q4 2024 after selling out during the quarter.
Brown Brothers Harriman & Co sold 25 CONMED shares in Q4 2024, an estimated $1.8K.
Brown Brothers Harriman & Co first reported a position in CONMED in Q1 2019 and held it in 21 quarters.
Brown Brothers Harriman & Co's CONMED position peaked at $83K in Q1 2019.
280 funds tracked by Wall St. Rank held CONMED as of Q4 2024.

Based on Brown Brothers Harriman & Co's 13F filing for Q4 2024, filed 12 Feb 2025.